Serologic Characterization of Bone-healing

This study has been withdrawn prior to enrollment.

(Lack of patients, lack of funding for analysis)

Sponsor:

ClinicalTrials.gov Identifier:

NCT00377884

First Posted: September 19, 2006

Last Update Posted: April 3, 2014

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

Collaborator:

CCBR Clinical Research Center, Aalborg, Denmark

Information provided by:

Northern Orthopaedic Division, Denmark

Purpose

Investigation of serologic bone markers in patients undergoing hip arthroplasty

Condition	Phase
Arthritis	Phase 1


Study Type:	Observational
Study Design:	Observational Model: Cohort Time Perspective: Prospective
Official Title:	Serologic Based Molecular Characterization of Bone-healing After Cementless Total Hip Arthroplasty

Further study details as provided by Northern Orthopaedic Division, Denmark:


Enrollment:	0
Study Start Date:	January 2004
Estimated Study Completion Date:	June 2009
Primary Completion Date:	June 2009 (Final data collection date for primary outcome measure)

Detailed Description:

Investigation of serologic bone markers in patients undergoing hip arthroplasty. Measured by frequent blood- and urine samples pre-operative and during the first post-operative year.

Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:	40 Years to 80 Years (Adult, Senior)
Sexes Eligible for Study:	All
Accepts Healthy Volunteers:	No
Sampling Method:	Probability Sample

Study Population

patients planned for cementless THR for OA in the hip

Criteria

Inclusion Criteria:

Ages 40-80 years

Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00377884

Locations


Denmark
Northern Orthopaedic Division
Aalborg, Northern Jutland, Denmark
Aalborg University Hospital
Aalborg, Denmark, 9000

Sponsors and Collaborators

Northern Orthopaedic Division, Denmark

CCBR Clinical Research Center, Aalborg, Denmark

Investigators


Principal Investigator:	Mogens B Laursen, MD, Phd	Northern Orthopaedic Division

More Information


Responsible Party:	Northern Orthopaedic Division, Orthopaedic Research Unit, Aarhus University - Aalborg Hospital, Denmark
ClinicalTrials.gov Identifier:	NCT00377884 History of Changes
Other Study ID Numbers:	ON-04-018-MBL
First Submitted:	September 18, 2006
First Posted:	September 19, 2006
Last Update Posted:	April 3, 2014
Last Verified:	April 2014

Keywords provided by Northern Orthopaedic Division, Denmark:


THA

To Top